These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6602955)

  • 1. [Immunologic studies in uremia].
    Dall'Aglio P; Chizzolini C; Brigati C; Ghiringhelli P
    Minerva Nefrol; 1983; 30(2 Suppl):19-26. PubMed ID: 6602955
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of the dinitrochlorobenzene test in evaluation of cellular immunity in uremic patients].
    Giacchino F; Triolo G; Coppo R; Alloatti S; Quarello F; Rotunno M; Martini PF; Segoloni G; Piccoli G; Vercellone A
    Minerva Nefrol; 1979; 26(3):343-8. PubMed ID: 318059
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunologic reactivity in uremic patients in hemodialysis].
    Rotolo U
    Recenti Prog Med; 1979 Feb; 66(2):116-23. PubMed ID: 312517
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological aspects of chronic uremia.
    Casciani CU; De Simone C; Bonini S; Gallucci MT; Matteucci G; Valesini G; Meli D; Masala C
    Kidney Int Suppl; 1978 Jun; (8):S49-54. PubMed ID: 278897
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemodialysis, continuous ambulatory peritoneal dialysis and cellular immunity.
    Collart F; Tielemans C; Dratwa M; Schandene L; Wybran J; Dupont E
    Proc Eur Dial Transplant Assoc; 1983; 20():190-4. PubMed ID: 6228939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of uremia and dialysis on cell-mediated immunity.
    Wojtulewicz-Kurkus J; Klepacka J; Skopińska E; Górski A; Nowaczyk M; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):997-1000. PubMed ID: 86344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic disturbances and levels of parathyroid hormone in uremic patients in replacement dialysis therapy.
    Angelini D; Carlini A; Mazzotta L; Mei E; Grassi R; Giusti R; Neri M; Fiorini I; Antonelli A
    Clin Nephrol; 1994 Oct; 42(4):246-50. PubMed ID: 7834917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rosette E and active rosette E tests in the evaluation of cell-mediated immunity in uremic patients].
    Giacchino F; Giachino G; Giraudo G; Boero R; Basolo B; Bancale E; Nigra M; Piccoli GB; Piccoli G
    Arch Sci Med (Torino); 1982; 139(1):19-22. PubMed ID: 7103704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity during RDT and the outcome of transplantation.
    Watson MA; Hamilton DN; Briggs JD; Macpherson SG; Tsakiris D
    Proc Eur Dial Transplant Assoc; 1981; 18():387-93. PubMed ID: 7036157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous ambulatory peritoneal dialysis and cellular immunity.
    Giangrande A; Cantù P; Limido A; de Francesco D; Malacrida V
    Proc Eur Dial Transplant Assoc; 1983; 19():372-9. PubMed ID: 6603616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and cell-mediated immunity in transfused uraemics.
    Dossetor JB; Kovithavongs T; Lao VS; Liburd EM; Lockwood JF; Schlaut J; Olson LA; Stiller CR
    Proc Eur Dial Transplant Assoc; 1973; 10(0):455-63. PubMed ID: 4278129
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated immunity in patients on long-term haemodialysis.
    Kauffman CA; Manzler AD; Phair JP
    Clin Exp Immunol; 1975 Oct; 22(1):54-61. PubMed ID: 1082396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is cell-mediated immunity in the uremic patient affected by blood transfusion?
    Fehrman I; Ringdén O; Möller E; Lundgren G; Groth CG
    Transplant Proc; 1981 Mar; 13(1 Pt 1):164-6. PubMed ID: 6455789
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune responses in uremia.
    Boulton-Jones JM; Vick R; Cameron JS; Black PJ
    Clin Nephrol; 1973; 1(6):351-60. PubMed ID: 4799080
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of larger molecules on cellular response in uremia.
    Giacchino F; Quarello F; Pozzato M; Giraudo G; Formica M; Quattrocchio G; Piccoli G
    Trans Am Soc Artif Intern Organs; 1983; 29():29-32. PubMed ID: 6608816
    [No Abstract]   [Full Text] [Related]  

  • 16. An immunosuppressive factor(s) in uremic sera.
    Kamata K; Okubo M; Marumo F
    Proc Clin Dial Transplant Forum; 1980; 10():47-50. PubMed ID: 6981113
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effect of hemodialysis on neutrophil migration: impact on humoral and cellular function.
    Pedersen JO; Knudsen F; Jersild C
    Kidney Int Suppl; 1988 Mar; 24():S86-9. PubMed ID: 3163061
    [No Abstract]   [Full Text] [Related]  

  • 19. Rosette-inhibiting activity of uraemic sera and the influence of dialysis.
    Rowiński W; Lukasiewicz H; Orlowski T; Sluźewska W
    Proc Eur Dial Transplant Assoc; 1972; 9():507-13. PubMed ID: 4677520
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell mediated immune reactivity in hemodialysis patients.
    Plavljanic D; Molnar V; Vitale B; Benkovic B
    Minerva Nefrol; 1979; 26(2):169-72. PubMed ID: 471343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.